New Screening Program Detects More Cancers

Medical Imaging Manager Chris Bilyeu. (Photo by Pat Blair)

Tomosynthesis, the 3D mammography screening program that Sheridan Memorial Hospital is considering buying, can detect 40 percent more breast cancers in men and women.

Chris Bilyeu, the hospital's medical imaging manager, elaborated in a recent interview with Sheridan Media.

He said equipment will allow the radiologist to manipulate the images for better vision. He said the hospital felt the timing is right to bring that technology into the community. As Sheridan Media reported earlier, the cost of the equipment is about $300,000, and the Sheridan Memorial Hospital Foundation has already raised $186,000. Bilyeu said there's more to the program than just the piece of equipment.

Bilyeu said the technology has been available for a few years, and it's something that the hospital has been looking at for a while. He said it's another program that would allow people to receive the care they need in the Sheridan community. Asked when the hospital might buy the equipment, Bilyeu said he's hopeful that could happen within the next year.

View another photo below.

Another view of Bilyeu. (Photo by Pat Blair)